Sarissa Capital Management as of March 31, 2016
Portfolio Holdings for Sarissa Capital Management
Sarissa Capital Management holds 16 positions in its portfolio as reported in the March 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Abbvie (ABBV) | 19.9 | $90M | 1.6M | 57.12 | |
| Ariad Pharmaceuticals | 18.1 | $82M | 13M | 6.39 | |
| Biogen Idec (BIIB) | 17.8 | $81M | 310k | 260.32 | |
| Medicines Company | 12.3 | $56M | 1.8M | 31.77 | |
| Quest Diagnostics Incorporated (DGX) | 9.1 | $41M | 575k | 71.45 | |
| Pacira Pharmaceuticals (PCRX) | 6.2 | $28M | 532k | 52.98 | |
| Intra Cellular Therapies (ITCI) | 4.1 | $19M | 675k | 27.80 | |
| Raptor Pharmaceutical | 2.8 | $13M | 2.7M | 4.60 | |
| Esperion Therapeutics (ESPR) | 2.4 | $11M | 633k | 16.91 | |
| Aegerion Pharmaceuticals | 2.1 | $9.5M | 2.6M | 3.70 | |
| Array BioPharma | 1.9 | $8.5M | 2.9M | 2.95 | |
| Apricus Bioscience | 1.9 | $8.4M | 15M | 0.58 | |
| Vivus | 0.8 | $3.6M | 2.6M | 1.40 | |
| AVEO Pharmaceuticals | 0.5 | $2.1M | 2.3M | 0.92 | |
| Repros Therapeutics | 0.2 | $971k | 1.0M | 0.97 | |
| Targacept Inc Conv Dtd convertible | 0.1 | $680k | 680k | 1.00 |
